Hyperferritinemia and inflammation

International Immunology

Volumn 29, Issue 9, 2017, Pages 401-409

  Kernan, Kate F ^a,b   Carcillo, Joseph A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Ferritin; Hemophagocytic lymphohistiocytosis; Hemophagocytosis; Iron; Macrophage activation

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; FREE RADICAL; IRON;

ARTICLE; BACTERIAL GROWTH; CELL FUNCTION; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; HYPERFERRITINEMIA; IMMUNE DYSREGULATION; IMMUNOMODULATION; INFLAMMATION; MORTALITY RISK; NONHUMAN; PRIORITY JOURNAL; ACUTE PHASE RESPONSE; ANIMAL; CATARACT; INNATE IMMUNITY; IRON METABOLISM DISORDER; METABOLISM;

ACUTE-PHASE REACTION; ANIMALS; CATARACT; FERRITINS; HEMOCHROMATOSIS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMATION; IRON; IRON METABOLISM DISORDERS;

EID: 85034223410     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxx031     Document Type: Article

References (108)

1. Cricthon, R. R. and Chaloteaux-Wauters, M. 1987. Iron transport and storage. Eur. J. Biochem. 164:485
2. Gozzelino, R. and Soares, M. P. 2014. Coupling heme and iron metabolism via ferritin H chain. Antioxid. Redox Signal. 20:1754
3. Cohen, L. A., Gutierrez, L., Weiss, A. et al. 2010. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116:1574
4. Kato, J., Kobune, M., Ohkubo, S. et al. 2007. Iron/IRP-1-dependent regulation of mRNA expression for transferrin receptor, DMT1 and ferritin during human erythroid differentiation. Exp. Hematol. 35:879
5. Harrison, P. M. and Arosio, P. 1996. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275:161
6. Thomson, A. M., Cahill, C. M., Cho, H. H. et al. 2005. The acute box cis-element in human heavy ferritin mRNA 5'-untranslated region is a unique translation enhancer that binds poly©-binding proteins. J. Biol. Chem. 280:30032
7. Fahmy, M. and Young, S. P. 1993. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296(Pt 1):175
8. Mikhael, M., Kim, S. F., Schranzhofer, M. et al. 2006. Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide. FEBS J. 273:3828
9. Korolnek, T. and Hamza, I. 2015. Macrophages and iron trafficking at the birth and death of red cells. Blood 125:2893
10. Delabya, C., Pilarda, N., Hetetb, G. et al. 2005. A physiological model to study iron recycling in macrophages. Exp. Cell Res. 310:43
11. Moldawer, L. L., Marano, M. A., Wei, H. et al. 1989. Cachectin/ tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 3:1637
12. Dinkla, S., van Eijk, L. T., Fuchs, B. et al. 2016. Inflammationassociated changes in lipid composition and the organization of the erythrocyte membrane. BBA Clin. 5:186
13. Piagnerelli, K., Boudjeltia, M., Brohee, D. et al. 2003. Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit. Care Med. 31:2156
14. Todd, J. C. 3rd and Mollitt, D. L. 1995. Effect of sepsis on erythrocyte intracellular calcium homeostasis. Crit. Care Med. 23:459
15. Reggiori, G., Occhipinti, G., De Gasperi, A., Vincent, J. L. and Piagnerelli, M. 2009. Early alterations of red blood cell rheology in critically ill patients. Crit. Care Med. 37:3041
16. Mendonça, R., Silveira, A. A. and Conran, N. 2016. Red cell DAMPs and inflammation. Inflamm. Res. 65:665
17. Schaer, C. A., Schoedon, G., Imhof, A., Kurrer, M. O. and Schaer, D. J. 2006. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ. Res. 99:943
18. Tenhunen, R., Marver, H. S. and Schmid, R. 1968. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl Acad. Sci. USA 61:748
19. Leimberg, M. J., Prus, E., Konijn, A. M. and Fibach, E. 2008. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J. Cell. Biochem. 103:1211
20. Donovan, A., Lima, C. A., Pinkus, J. L. et al. 2005. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1:191
21. Corna, G., Caserta, I., Monno, A. et al. 2016. The repair of skeletal muscle requires iron recycling through macrophage ferroportin. J. Immunol. 197:1914
22. Torti, F. M. and Torti, S. V. 2002. Regulation of ferritin genes and protein. Blood 99:3505
23. Podmore, C., Meidtner, K., Schulze, M. B. et al. 2016. Association of multiple biomarkers of iron metabolism and type 2 diabetes: The EPIC-InterAct Study. Diabetes Care 39:572
24. Marques, L., Negre-Salvayre, A., Costa, L. and Canonne-Hergaux, F. 2016. Iron gene expression profile in atherogenic Mox macrophages. Biochim. Biophys. Acta 1862:1137
25. Silvestre, O. M., Gonçalves, A., Nadruz, W. Jr et al. 2017. Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study. Eur. J. Heart Fail. 19:340
26. Pieracci, F. M. and Barie, P. S. 2005. Iron and the risk of infection. Surg. Infect. (Larchmt.) 6(Suppl. 1):S41
27. Wooldridge, K. G. and Williams, P. H. 1993. Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol. Rev. 12:325
28. Letendre, E. D. and Holbein, B. E. 1984. Mechanism of impaired iron release by the reticuloendothelial system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect. Immun. 44:320
29. Sazawal, S., Black, R. E., Kabole, I., Dutta, A., Dhingra, U. and Ramsan, M. 2014. Effect of iron/folic Acid supplementation on the outcome of malaria episodes treated with sulfadoxine-pyrimethamine. Malar. Res. Treat. 2014:625905
30. Kent, S. and Dunn, D. 1993. Etiology of hypoferremia in a recently sedentary Kalahari village. Am. J. Trop. Med. Hyg. 48:554
31. Alvarez-Hernández, X., Licéaga, J., McKay, I. C. and Brock, J. H. 1989. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab. Invest. 61:319
32. Corna, G., Campana, L., Pignatti, E. et al. 2010. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95:1814
33. Recalcati, S., Locati, M., Marini, A. et al. 2010. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 40:824
34. Seifert, M., Nairz, M., Schroll, A., Schrettl, M., Haas, H. and Weiss, G. 2008. Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology 213:767
35. Konijn, A. M., Carmel, N., Levy, R. and Hershko, C. 1981. Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis. Br. J. Haematol. 49:361
36. Recalcati, S., Invernizzi, P., Arosio, P. and Cairo, G. 2008. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J. Autoimmun. 30:84
37. Kwak, E. L., Larochelle, D. A., Beaumont, C., Torti, S. V. and Torti, F. M. 1995. Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J. Biol. Chem. 270:15285
38. Pham, C. G., Bubici, C., Zazzeroni, F. et al. 2004. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:529
39. Wei, Y., Miller, S. C., Tsuji, Y., Torti, S. V. and Torti, F. M. 1990. Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem. Biophys. Res. Commun. 169:289
40. Rogers, J. T., Andriotakis, J. L., Lacroix, L., Durmowicz, G. P., Kasschau, K. D. and Bridges, K. R. 1994. Translational enhancement of H-ferritin mRNA by interleukin-1 beta acts through 5' leader sequences distinct from the iron responsive element. Nucleic Acids Res. 22:2678
41. Huang, B. W., Miyazawa, M. and Tsuji, Y. 2014. Distinct regulatory mechanisms of the human ferritin gene by hypoxia and hypoxia mimetic cobalt chloride at the transcriptional and post-transcriptional levels. Cell Signal. 26:2702
42. Tran, T. N., Eubanks, S. K., Schaffer, K. J., Zhou, C. Y. and Linder, M. C. 1997. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90:4979
43. Cragg, S. J., Wagstaff, M. and Worwood, M. 1981. Detection of a glycosylated subunit in human serum ferritin. Biochem. J. 199:565
44. Ghosh, S., Hevi, S. and Chuck, S. L. 2004. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood 103:2369
45. Fautrel, B., Moël, G., Saint-Marcoux, B. et al. 2001. Diagnostic value of and glycosylated ferritin in adult onset Still's disease. J. Rheumatol. 28:12
46. Fautrel, B. 2008. Adult-onset Still disease. Best Pract. Res. Clin. Rheumatol. 22:773
47. Van Reeth, C. Le Moel, G., Lasne, Y. et al. 1994. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J. Rheumatol. 21:890
48. Higashi, S., Ota, T. and Eto, S. Biochemical analysis of ferritin subunits in sera from adult Still's disease patients. Rheumatol Int. 15:45
49. Zollner, R. C., Kern, P., Steininger, H. et al. 1997. Hyperferritinemia in Still syndrome in the adult and reactive hemophagocytic syndrome. Med. Klin. (Munich) 92:494
50. Lambotte, O., Cacoub, P., Costedoat, N. et al. 2003. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J. Rheumatol. 30:1027
51. Wang, Z., Wang, Y. N., Feng, C. C., Tian, L. P. and Chen, X. 2009. The early diagnosis and clinical analysis of 57 cases of acquired hemophagocytic lymphohistiocytosis. Zhonghua Nei Ke Za Zhi 48:312
52. Benm'rad, M., Leclerc-Mercier, S., Blanche, P. et al. 2009. Druginduced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 88:131
53. Lambotte, O., Costedoat-Chalumeau, N., Amoura, Z., Piette, J. C. and Cacoub, P. 2002. Drug-induced hemophagocytosis. Am. J. Med. 112:592
54. Worwood, M., Cragg, S. J., Wagstaff, M. and Jacobs, A. 1979. Binding of human serum ferritin to concanavalin A. Clin. Sci. (Lond.) 56:83
55. Muylle, L., Blockx, P. and Becquart, D. 1986. Binding of serum ferritin to concanavalin A in patients with malignancy. Biomed. Pharmacother. 40:225
56. Takakuwa, Y., Miyazawa, K., Yoshikawa, O. and Toyama, K. 1994. The clinical significance of glycosylated ferritin in iron overloads and hematopoietic malignancies. Rinsho Ketsueki 35:744
57. Vignes, S., Le Moël, G., Fautrel, B., Wechsler, B., Godeau, P. and Piette, J. C. 2000. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease. Ann. Rheum. Dis. 59:347
58. Fan, Y., Yamada, T., Shimizu, T. et al. 2009. Ferritin expression in rat hepatocytes and Kupffer cells after lead nitrate treatment. Toxicol. Pathol. 37:209
59. Zager, R. A., Johnson, A. C. and Hanson, S. Y. 2004. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int. 66:144
60. Wesselius, L. J., Nelson, M. E. and Skikne, B. S. 1994. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am. J. Respir. Crit. Care Med. 150:690
61. Ferring-Appel, D., Hentze, M. W. and Galy, B. 2009. Cellautonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood 113:679
62. Cazzola, M., Bergamaschi, G., Tonon, L. et al. 1997. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 90:814
63. Colafrancesco, S., Priori, R., Alessandri, C. et al. 2014. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia. Immunol. Res. 60:177
64. Schaer, D. J., Schaer, C. A., Schoedon, G., Imhof, A. and Kurrer, M. O. 2006. Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur. J. Haematol. 77:432
65. Ruddell, R. G., Hoang-Le, D., Barwood, J. M. et al. 2009. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49:887
66. Freeman, G. J., Casasnovas, J. M., Umetsu, D. T. and DeKruyff, R. H. 2010. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 235:172
67. Fargion, S., Fracanzani, A. L., Brando, B., Arosio, P., Levi, S. and Fiorelli, G. 1991. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 78:1056
68. Broxmeyer, H. E., Williams, D. E., Geissler, K. et al. 1989. Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood 73:74
69. Yamashita, M., Harada, G., Matsumoto, S. E. et al. 2014. Suppression of immunoglobulin production in human peripheral blood mononuclear cells by monocytes via secretion of heavychain ferritin. Immunobiology 219:149
70. Li, R., Luo, C., Mines, M., Zhang, J. and Fan, G. H. 2006. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J. Biol. Chem. 281:37616
71. Gray, C. P., Arosio, P. and Hersey, P. 2002. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 99:3326
72. Harada, T., Baba, M., Torii, I. and Morikawa, S. 1987. Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell. Immunol. 109:75
73. Wigginton, J. M. 1995. Reversal of ferritin-mediated immunosuppression by levamisole: a rationale for its application to management of the acquired immune deficiency syndrome (AIDS). Med. Hypotheses 44:85
74. Carcillo, J. A., Sward, K., Halstead, E.S. et al. 2016. A systemic inflammation mortality risk assessment contingency table for severe sepsis. Pediatr. Crit. Care Med. 18:143
75. Garcia, P. C., Longhi, F., Branco, R. G., Piva, J. P., Lacks, D. and Tasker, R. C. 2007. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 96:1829
76. Bennett, T. D., Hayward, K. N., Farris, R. W., Ringold, S., Wallace, C. A. and Brogan, T. V. 2011. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr. Crit. Care Med. 12:e233
77. Tonial, C. T., Garcia, P. C. R., Schweitzer, L. C. et al. 2017. Cardiac dysfunction at echocardiogram and ferritin as early markers of severity in pediatric sepsis. J. Pediatr. (Rio J.) S0021-7557:30032
78. Castillo, L. and Carcillo, J. 2009. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr. Crit. Care Med. 10:387
79. Rosário, C., Zandman-Goddard, G., Meyron-Holtz, E. G., D'Cruz, D. P. and Shoenfeld, Y. 2013. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 11:185
80. Rosário, C. and Shoenfeld, Y. 2014. The hyperferritinemic syndrome. Isr. Med. Assoc. J. 16:664
81. Jordan, M. B., Allen, C. E., Weitzman, S., Filipovich, A. H. and McClain, K. L. 2011. How I treat hemophagocytic lymphohistiocytosis. Blood 118:4041
82. Zur Stadt, U., Beutel, K., Kolberg, S. et al. 2006. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum. Mutat. 27:62
83. Behrens, E. M. 2008. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Autoimmun. Rev. 7:305
84. Tang, Y., Xu, X., Song, H. et al. 2008. Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome. Br. J. Haematol. 143:84
85. Akashi, K., Hayashi, S., Gondo, H. et al. 1994. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br. J. Haematol. 87:243
86. Henter, J. I., Elinder, G., Söder, O., Hansson, M., Andersson, B. and Andersson, U. 1991. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78:2918
87. Grom A. A. 2016. Macrophage activation syndrome. In Petty, R. E., Laxer, R. M., Lindsley, C. B. and Wedderburn, L., eds, Textbook of Pediatric Rheumatology, p. 642, Elsevier Inc., Philadelphia, PA
88. Zhang, K., Jordan, M. B., Marsh, R. A. et al. 2011. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 118:5794
89. Cetica, V., Sieni, E., Pende, D. et al. 2016. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J. Allergy Clin. Immunol. 137:188
90. Kernan, K., Ghaloul-Gonzalez, L., Sethi, R. et al. 2016. Genetic variants associated with hyperinflammation in septic shock. Crit. Care Med. 44:427
91. Behrens, E. M., Canna, S. W., Slade, K. et al. 2011. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J. Clin. Invest. 121:2264
92. Tsujimoto, H., Ono, S., Matsumoto, A. et al. 2006. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J. Hepatol. 45:836
93. Petrasek, J., Dolganiuc, A., Csak, T., Kurt-Jones, E. A. and Szabo, G. 2011. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140:697
94. Muruve, D. A., Pétrilli, V., Zaiss, A. K. et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103
95. Elmaagacli, A., Steckel, N., Koldehoff, M. et al. 2010. Toll-likereceptor expression and cellular immune reconstitution in AMLpatients with elevated serum ferritin levels after allogeneic transplant. Blood 116:1049
96. Shakoory, B., Carcillo, J. A., Chatham, W. W. et al. 2016. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit. Care Med. 44:275
97. Lamkanfi, M., Mueller, J. L., Vitari, A. C. et al. 2009. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187:61
98. Coll, R. C., Robertson, A. A., Chae, J. J. et al. 2015. A smallmolecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21:248
99. Li, J., Wang, Q., Zheng, W. et al. 2014. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93:100
100. Davì, S., Minoia, F., Pistorio, A. et al.; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. 2014. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 66:2871
101. Boom, V., Anton, J., Lahdenne, P. et al. 2015. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 13:55
102. Henter, J. I., Horne, A., Aricó, M. et al. 2007. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48:124
103. Haytoglu, Z., Yazici, N. and Erbay, A. 2017. Secondary hemophagocytic lymphohistiocytosis: do we really need chemotherapeutics for all patients? J. Pediatr. Hematol. Oncol. 39:e106
104. Demirkol, D., Yildizdas, D., Bayrakci, B. et al.; Turkish Secondary HLH/MAS Critical Care Study Group. 2012. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/ sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit. Care 16:R52
105. Coca, A., Bundy, K. W., Marston, B., Huggins, J. and Looney, R. J. 2009. Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin. Immunol. 132:10
106. Horne, A., Wickström, R., Jordan, M. B. et al. 2017. How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis? Curr. Treat. Options Neurol. 19:3
107. Dinarello, C. A., Novick, D., Kim, S. and Kaplanski, G. 2013. Interleukin-18 and IL-18 binding protein. Front. Immunol. 4:289
108. Canna, S. W., Girard, C., Malle, L. et al. 2017. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. J. Allergy Clin. Immunol. 139:1698